Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study

Thyroid , Vol. 0, No. 0.


http://ift.tt/2oeZBM6